Showing results (121-130 of 1,781) with videos related to

Sort By:
Pageof 179
Dermatology and Therapy|July 30, 2024
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 TrialsApril W Armstrong, Matthias Augustin, Jennifer L Beaumont, et al.
Dermatology and Therapy|August 17, 2024
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical TrialsKenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, et al.
Dermatology and Therapy|August 16, 2024
Restoration of the Ultrastructural Integrity of the Dermal Collagen Network by 12-Week Ingestion of Special Collagen PeptidesDorothee Dähnhardt, Stephan Dähnhardt-Pfeiffer, Dörte Segger, et al.
Dermatology and Therapy|June 26, 2024
Disease Course, Treatment Patterns and Goals Among Patients with Non-segmental Vitiligo Across Europe and the United StatesDavid Rosmarin, Ahmed M Soliman, Simran Marwaha, et al.
Dermatology and Therapy|December 30, 2022
Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims DataAmit Garg, Haley B Naik, Afsaneh Alavi, et al.
Dermatology and Therapy|January 1, 2023
Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled StudyStephen K Tyring, Phoebe Rich, Yayoi Tada, et al.
Dermatology and Therapy|November 27, 2022
Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support ProgramWayne Gulliver, Melinda J Gooderham, Baojin Zhu, et al.
Dermatology and Therapy|December 21, 2022
Supersaturation as a Galenic Concept for Improving the Cutaneous Bioavailability of Drugs in Topical TherapyJohannes Wohlrab, Adina Eichner
Dermatology and Therapy|December 21, 2022
Topical Mechlorethamine for the Treatment of Psoriasis: A Report of Two Cases and Literature ReviewLauren M Fahmy, Bradley D Kwinta, Celine M Schreidah, et al.
Dermatology and Therapy|December 12, 2022
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)Paolo Gisondi, Alice B Gottlieb, Boni Elewski, et al.
Pageof 179